BioSpace News Archive

Business

For Eyes To Increase Access To Eye Health In Owings Mills With New Location

For Eyes to bring affordable optical care and high-quailty frames to Baltimore County

September 14, 2018
·
2 min read
Business

For Eyes To Open Four New Locations In Southern California

Affordable eye care and high-quality frames make their way to the Golden State

September 14, 2018
·
2 min read
Policy

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of OPKO Health - OPK

Pomerantz LLP is investigating claims on behalf of investors of OPKO Health

September 14, 2018
·
1 min read
Biotech Beach

Dr. Prudence Hall Responds To News Story Regarding State Board Settlement Of Dispute

In the wake of the recent People Magazine news story on Tuesday, September 11, which was picked up by other publications as late as today, regarding a dispute resolution between the medical board and pioneering physician, Dr. Prudence Hall, she has issued the following statement

September 14, 2018
·
1 min read
FDA

Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults ADDING MULTIMEDIA

Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved AJOVYTM (fremanezumab-vfrm) injection for the preventive treatment of migraine in adults.

September 14, 2018
·
9 min read
FDA

Sun Pharma and SPARC Announce US FDA Approval of XELPROS™ to Treat Open-angle Glaucoma or Ocular Hypertension

XELPROSTM (latanoprost ophthalmic emulsion) 0.005% for topical ophthalmic use is the first and only benzalkonium chloride-free (BAK-free) form of latanoprost

September 14, 2018
·
9 min read
Drug Development

Alnylam Announces Publication in Circulation of Exploratory Cardiac Endpoint Data from APOLLO Phase 3 Study of Patisiran

Published Data From the APOLLO Study Show That Patisiran Improved Markers of Cardiomyopathy in Patients with Hereditary ATTR Amyloidosis with Polyneuropathy –

September 14, 2018
·
13 min read
Duchesnay Inc. to Present a Poster on Adherence, Persistence and Healthcare Costs Associated with Ospemifene at 2018 Annual Meeting of the North American Menopause Society (NAMS)

Duchesnay Inc. announced today that it will present a poster on the topic of ospemifene at the 2018 Annual Meeting of the North American Menopause Society (NAMS) in San Diego.

September 14, 2018
·
1 min read
Genetown

Corindus to Feature the CorPath® GRX System at the Transcatheter Cardiovascular Therapeutics 2018 Conference

Breakfast symposium and immersive booth activities highlight capabilities of vascular robotic technology and importance of remote access to care

September 14, 2018
·
6 min read
BioCapital

CASI Pharmaceuticals Announces $48.5 Million Private Placement

CASI Pharmaceuticals, Inc. announces today a $48.5 million private placement.

September 14, 2018
·
6 min read